Attached files

file filename
8-K - FORM 8-K - ALIMERA SCIENCES INCd382118d8k.htm
EX-99.1 - PRESS RELEASE OF ALIMERA SCIENCES, INC. DATED JULY 18, 2012 - ALIMERA SCIENCES INCd382118dex991.htm
EX-4.10 - FORM OF WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCK - ALIMERA SCIENCES INCd382118dex410.htm
EX-4.11 - FORM OF REGISTRATION RIGHTS AGREEMENT - ALIMERA SCIENCES INCd382118dex411.htm
EX-99.2 - INVESTOR PRESENTATION SLIDES - ALIMERA SCIENCES INCd382118dex992.htm
EX-10.36 - SECURITIES PURCHASE AGREEMENT - ALIMERA SCIENCES INCd382118dex1036.htm
EX-3.5 - FORM OF CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK - ALIMERA SCIENCES INCd382118dex35.htm

Exhibit 3.6

AMENDMENT NO. 1

TO THE AMENDED AND RESTATED BYLAWS

OF

ALIMERA SCIENCES, INC., A DELAWARE CORPORATION

Effective upon the filing of that certain Certificate of Designation of Series A Convertible Preferred Stock, Section 2.11 of the Amended and Restated Bylaws (the “Bylaws”) of Alimera Sciences, Inc., a Delaware corporation, shall be amended to add a second sentence, stating as follows:

“Notwithstanding the foregoing, the stockholders holding Series A Preferred Stock (as defined in the Certificate of Designation of Series A Convertible Preferred Stock filed by the Corporation with the Secretary of State of the State of Delaware (the “Certificate of Designation”)), may take any exclusive action required or permitted to be taken by the stockholders holding Series A Preferred Stock of the Corporation as set forth in the Certificate of Designation by written consent at any time.”

The effective date of the Amendment No. 1 to the Bylaws of Alimera Sciences, Inc. is             , 2012.